Treatment of Mesh-Associated Abscess Using An Incision-Free Technique: A Case Series
Treatment of Mesh-Associated Abscess Using An Incision-Free Technique: A Case Series
Treatment of Mesh-Associated Abscess Using An Incision-Free Technique: A Case Series
2019;8(1):25-28
Patients who undergo pelvic mesh placement are at risk for developing
infectious complications. In the case of an abscess associated with the
Case Reports
mesh, removal is often necessary for resolution of the infection. This
report describes two cases of delayed abscesses associated with mesh Case 1
for posterior compartment prolapse and stress urinary incontinence. De-
finitive treatment for both involved complete removal of the offending
portion of mesh without the need for an incision. In patients who de- Case description
velop infectious complications involving pelvic mesh, providers must
consider removal of the mesh as a method for source control. Here, ex- We first present the case of a 70-year-old G3P3003 with a com-
ploration of an existing sinus tract allowed for complete mesh removal plex surgical history involving multiple prolapse and incon-
without the need for extensive dissection. This is especially important tinence procedures, presenting with a recurrent right gluteal
in those with medical comorbidities resulting in poor wound healing. abscess. Her medical history includes hypertension, hyperlipi-
demia, and diverticulitis. In addition to an abdominal hysterec-
Keywords: Pelvic abscess; Pelvic mesh; Surgical technique tomy, her pelvic reconstructive surgical history includes a ret-
ropubic midurethral sling in 2005 followed by a laparoscopic
sacral colpopexy (Gynemesh, Ethicon Inc., Sommervile, NJ,
USA) and transobturator sling (TVT-O, Ethicon Inc., Somer-
Introduction ville, NJ, USA) a year later. She then underwent a rectocele
repair and Avaulta (C.R. Bard, Inc., Murray Hill, NJ, USA)
The use of polypropylene mesh is a mainstay in the treatment mesh procedure with excision of a previously placed sling (it
of stress urinary incontinence (SUI) and is one of the most well is unclear which sling was removed based on the operative
studied surgical modalities in women’s health since its intro- report) and placement of a pubovaginal sling.
duction in the mid-1990s [1, 2]. Mid-urethral slings and pelvic The patient had undergone transcutaneous incision and
mesh for prolapse have undergone a number of permutations drainage of a right ischioanal fossa abscess on two separate
all with the goal of improving surgical outcomes while de- occasions without mesh removal at an outside institution. After
creasing potential complications. Type I mesh remains in use the second procedure, vaginal mesh exposure was noted and
as the standard of care for treatment of SUI [3]. More recently, she was referred to our institution. Initial exam revealed a re-
concerns around the use of synthetic mesh for pelvic organ gion of scarring in the perianal area, to the right of the midline
prolapse (POP) have resulted in a decrease in use [4]. Spe- consistent with an intermittently draining buttock abscess. At
cific concerns include the risks of scaring, exposure, pain, and her initial visit, it was not fluctuant, with no acute inflamma-
infectious complications. In any patient with a foreign body, tion or tenderness. The scarred area was adjacent to one of the
there is risk of long-term infectious complications. We present posterior Avaulta insertion points. In the midline of the distal
two cases of mesh associated with abscess formation remote vagina there was a mesh exposure of approximately 2.0 × 2.0
from initial placement and removed through an existing drain- cm. No other mesh exposures were noted.
At that time, we recommended removal of all graft material
with possible exploration of the right pelvic side wall and right
Manuscript submitted March 1, 2019, accepted March 12, 2019 ischioanal fossa in order to treat and avoid additional recur-
rence of her right buttock abscess. The patient was counseled
aDepartment of Obstetrics and Gynecology, Vanderbilt University Medical that a staged procedure may be necessary to remove all mesh.
Center, Nashville, TN, USA
bCorresponding Author: Joseph Panza, Department of Obstetrics and Gyne-
cology, Vanderbilt University Medical Center, 1161 21st Ave. South B1100 Surgical course
MCN, Nashville, TN 37232-2521, USA. Email: joseph.r.panza@vumc.org
doi: https://doi.org/10.14740/jcgo538 The initial procedure used the exposed vaginal mesh as a start-
Articles © The authors | Journal compilation © J Clin Gynecol Obstet and Elmer Press Inc™ | www.jcgo.org
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits 25
unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited
Treatment of Mesh-Associated Abscess J Clin Gynecol Obstet. 2019;8(1):25-28
Surgical course
Case 2
26 Articles © The authors | Journal compilation © J Clin Gynecol Obstet and Elmer Press Inc™ | www.jcgo.org
Panza et al J Clin Gynecol Obstet. 2019;8(1):25-28
Acknowledgments
None to declare.
While the use of transvaginal mesh for POP has decreased, The authors have no conflict of interest or disclosures.
there remains a large cohort of women who have had this
material placed and are at risk for complications in the fu-
ture. The cases presented here highlight the importance of Informed Consent
considering mesh-related infections in patients found to have
a pelvic abscess, specifically in the setting of a draining si- Not applicable.
nus.
Interestingly, both cases involved the use of type 1 mesh,
which historically has less infectious complications due to its Author Contributions
macroporous design and ability to integrate into host tissue. It
is thought that vaginal exposure is the primary risk factor for JP and PS contributed to drafting the article. CZ revised the
infectious complications. Two other case reports were identi- article for critically important content and gave final approval
fied as involving abscesses associated with type 1 mesh. The for submission.
first was associated with a Safyre T adjustable kit (Promedon,
Cordoba, Argentina), which has silicone arms. The patient in
this case had additional risk factors of immunocompromising References
condition following treatment for breast cancer [5]. The sec-
ond was associated with an Aris kit (Coloplast, Denmark), in 1. Welk B, Al-Hothi H, Winick-Ng J. Removal or revision
which a patient developed an obturator abscess 1.5 years after of vaginal mesh used for the treatment of stress urinary
placement [6]. incontinence. JAMA Surg. 2015;150(12):1167-1175.
The second case in this report presents multiple risk fac- 2. Jonsson Funk M, Siddiqui NY, Kawasaki A, Wu JM.
tors for infectious complications, including poorly controlled Long-term outcomes after stress urinary incontinence
diabetes, current tobacco use, and a history of multiple mesh surgery. Obstet Gynecol. 2012;120(1):83-90.
surgeries and exposures. Thus, removing the mesh without 3. Viereck V, Bader W, Lobodasch K, Pauli F, Bentler R,
making an incision in the adductor compartment, an area prone Kolbl H. Guideline-Based Strategies in the Surgical
to infection, was a priority. Initial imaging did not clearly re- Treatment of Female Urinary Incontinence: The New
veal any mesh associated with the abscess; it was not until an Gold Standard is Almost the Same as the Old One. Ge-
ultrasound of the adductor showed an unmistakable piece of burtshilfe Frauenheilkd. 2016;76(8):865-868.
mesh that the patient was taken to the operating room. Other 4. Skoczylas LC, Turner LC, Wang L, Winger DG, Shep-
cases have also shown that mesh is rarely visible on MRI and herd JP. Changes in prolapse surgery trends relative to
computed tomography (CT); thus a high degree of suspicion FDA notifications regarding vaginal mesh. Int Urogy-
must be maintained in patients with a history of mesh place- necol J. 2014;25(4):471-477.
ment [7]. We postulate that ultrasound is an effective, inex- 5. Brubaker L, Norton PA, Albo ME, Chai TC, Dandreo
pensive tool for locating mesh and assisting in pre-operative KJ, Lloyd KL, Lowder JL, et al. Adverse events over two
planning. years after retropubic or transobturator midurethral sling
For both patients, treatment was ultimately easily accom- surgery: findings from the Trial of Midurethral Slings
plished by complete removal, by extraction, of the foreign (TOMUS) study. Am J Obstet Gynecol. 2011;205(5):498
body through an infectious sinus tract identified on physical e491-496.
Articles © The authors | Journal compilation © J Clin Gynecol Obstet and Elmer Press Inc™ | www.jcgo.org 27
Treatment of Mesh-Associated Abscess J Clin Gynecol Obstet. 2019;8(1):25-28
6. Martinez Franco E, Rojo N, Amat Tardiu L. Obturator 7. Geoffrion R, Murphy M, Mainprize T, Ross S. Closing
abscess with spread to the thigh muscles after a tran- the chapter on obtape: a case report of delayed thigh
sobturator tension-free vaginal tape. Int Urogynecol J. abscess and a literature review. J Obstet Gynaecol Can.
2016;27(6):973-976. 2008;30(2):143-147.
28 Articles © The authors | Journal compilation © J Clin Gynecol Obstet and Elmer Press Inc™ | www.jcgo.org